Earnings - June 6th 2008

8:03AM Trina Solar beats by $0.03, beats on revs; guides Q2 revs above consensus; guides FY08 revs above consensus (TSL) 49.63 : Reports Q1 (Mar) earnings of $0.51 per share, $0.03 better than the First Call consensus of $0.48; revenues rose 183.7% year/year to $120.7 mln vs the $116.9 mln consensus. Co issues upside guidance for Q2, sees Q2 revs of $169-177 mln vs. $168.09 mln consensus; expects to ship between 43 MW and 45 MW of PV modules. Co issues upside guidance for FY08, sees FY08 revs of $770-808 mln vs. $756.46 mln consensus; sees PV module shipments between 200 MW to 210 MW.

7:14AM Inspire Pharm announces achievement of primary endpoint in Phase 3 trial with Denufosol for Cystic Fibrosis (ISPH) 3.85 : Co announces top-line results from the 352-patient, double-blind, 24-week placebo-controlled portion of its Phase 3 trial with denufosol tetrasodium inhalation solution for the treatment of cystic fibrosis.The trial demonstrated statistical significance for its primary efficacy endpoint, which was the change in FEV1 from baseline at the trial endpoint. Patients treated with denufosol had a statistically significant improvement in FEV1 compared to placebo. On average, patients on denufosol improved relative to baseline whereas patients on placebo remained essentially unchanged. The treatment effect of denufosol increased over the 24-week placebo-controlled period, and available preliminary data from approximately 210 patients who have completed the ongoing open-label safety extension suggest that FEV1 continued to improve during the extension period from weeks 24 to 48

12:44AM Network Equipment Technologies expects Q1 revenue to fall short of expectations (NWK) 5.00 : Co issues downside guidance for Q1 (Jun), sees Q1 (Jun) revs of $16.0-20.0 mln vs. $26.16 mln First Call consensus. "We continue to see many government programs in which we can participate. However, it has become apparent that at least in the near term we won't receive the volume of orders we had previously expected," said C. Nicholas Keating, President and CEO. Co expects a partial rebound in revenue from the government in later quarters of FY09, but believes that its government business is likely to be down through the end of the calendar year. As a result, annual revenue for FY09 is likely to be down compared to FY08.